L’Oreal USA subsidiary SkinCeuticals USA has appointed new leaders for its GM and VP roles. 

Angela Hildebrand will be the brand’s GM, with Amy Sloan taking on the new job of senior VP of business strategy and growth. 

Hildebrand, who has more than 20 years of expertise in the aesthetic sector, will concentrate on maintaining and developing commercial, medical, and innovative growth. She formerly served as the SVP of sales at SkinCeuticals for eight years and was the GM of medical commercial strategy at L’Oreal Dermatological Beauty. 

In order to keep up the momentum with product innovation, services, business models and partnerships, and consumer experience across all channels, the new senior VP Sloan will also concentrate on strategic growth initiatives and continue to lead the marketing, retail, digital/e-retail, and advocacy & influence teams.

“With their collective knowledge, expertise, and dedication to excellence, Angela and Amy’s leadership are poised to take SkinCeuticals to new heights,” said Tina Fair, president, L’Oreal dermatological beauty division, North America.  

SkinCeuticals was founded in 1994 and was acquired by L’Oreal in 2005. It is now available in more than 6000 medical offices across the US.